Declaration of Helsinki, 2008

Journal of Postgraduate Medicine - Tập 55 Số 2 - Trang 131-134 - 2009
Kanchan Puri1, Kallur Suresh1, NJ Gogtay1, Urmila Thatte1
1Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Parel, Mumbai - 400 012, India.

Tóm tắt

The Declaration of Helsinki (DoH) was adopted by the World Medical Association (WMA) in 1964, as a statement of ethical principles, to provide guidance to physicians and other participants in medical research involving human subjects. Having undergone several amendments, the most recent version was approved on 18 October 2008, by the WMA General Assembly at Seoul, South Korea, replacing all previous versions. This version highlights issues such as, participant safety, the need to include participants from otherwise underrepresented groups, clinical trial registration, post-study access, usage of data and human tissues, compensating participants with research-related injury, and usage of placebo. In this article, we discuss the major aspects of the 2008 version, including the impact of this version on all stakeholders in research, including, investigators, ethics committee members, sponsors, authors, editors, and reviewers.

Từ khóa


Tài liệu tham khảo

De Angelis, 2006, Is this clinical trial fully registered? A statement from the international committee of medical journal, Haematologica, 91, 293

Tharayan, 2008, Registering clinical trials in India a scientific and ethical imperative, Natl Med J India, 21, 31

Satyanarayana, 2008, Statement on publishing clinical trials in Indian biomedical journals, J Postgrad Med, 54, 78, 10.4103/0022-3859.40766

Franklin, 2002, What makes placebo-controlled trials unethical?, Am J Bioeth, 2, 3, 10.1162/152651602317533523

Moutel, 2005, Study group Communication of pharmacogenetic research results to HIV-infected treated patients: Standpoints of professionals and patients, Eur J Hum Genet, 13, 1055, 10.1038/sj.ejhg.5201450